Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.

Cite

CITATION STYLE

APA

Vicente, M. A., & Morte, E. (2022). Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient. Revista Chilena de Infectologia, 39(3), 357–360. https://doi.org/10.4067/s0716-10182022000200357

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free